Cargando…

Community-based specialist palliative care is associated with reduced hospital costs for people with non-cancer conditions during the last year of life

BACKGROUND: Community-based palliative care is associated with reduced hospital costs for people dying from cancer. It is unknown if reduced hospital costs are universal across multiple life-limiting conditions amenable to palliative care. The aim of this study was to determine if community-based pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Spilsbury, Katrina, Rosenwax, Lorna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721619/
https://www.ncbi.nlm.nih.gov/pubmed/29216873
http://dx.doi.org/10.1186/s12904-017-0256-2
_version_ 1783284845272629248
author Spilsbury, Katrina
Rosenwax, Lorna
author_facet Spilsbury, Katrina
Rosenwax, Lorna
author_sort Spilsbury, Katrina
collection PubMed
description BACKGROUND: Community-based palliative care is associated with reduced hospital costs for people dying from cancer. It is unknown if reduced hospital costs are universal across multiple life-limiting conditions amenable to palliative care. The aim of this study was to determine if community-based palliative care provided to people dying from non-cancer conditions was associated with reduced hospital costs in the last year of life and how this compared with people dying from cancer. METHOD: A retrospective population-based cohort study of all decedents in Western Australia who died January 2009 to December 2010 from a life-limiting condition considered amenable to palliative care. Hospital costs were assigned to each day of the last year of life for each decedent with a zero cost applied to days not in hospital. Day-specific hospital costs averaged over all decedents (cohort averaged) and decedents in hospital only (inpatient averaged) were estimated. Two-part models and generalised linear models were used. RESULTS: The cohort comprised 12,764 decedents who, combined, spent 451,236 (9.7%) days of the last year of life in hospital. Overall, periods of time receiving community-based specialist palliative care were associated with a 27% decrease from A$112 (A$110-A$114) per decedent per day to $A82 (A$78-A$85) per decedent per day of CA hospital costs. Community-based specialist palliative care was also associated a reduction of inpatient averaged hospital costs of 9% (7%-10%) to A$1030 per hospitalised decedent per day. Hospital cost reductions were observed for decedents with organ failures, chronic obstructive pulmonary disease, Alzheimer’s disease, Parkinson’s disease and cancer but not for motor neurone disease. Cost reductions associated with community-based specialist palliative care were evident 4 months before death for decedents with cancer and by one to 2 months before death for decedents dying from other conditions. CONCLUSION: Community-based specialist palliative care was associated with hospital cost reductions across multiple life-limiting conditions.
format Online
Article
Text
id pubmed-5721619
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57216192017-12-12 Community-based specialist palliative care is associated with reduced hospital costs for people with non-cancer conditions during the last year of life Spilsbury, Katrina Rosenwax, Lorna BMC Palliat Care Research Article BACKGROUND: Community-based palliative care is associated with reduced hospital costs for people dying from cancer. It is unknown if reduced hospital costs are universal across multiple life-limiting conditions amenable to palliative care. The aim of this study was to determine if community-based palliative care provided to people dying from non-cancer conditions was associated with reduced hospital costs in the last year of life and how this compared with people dying from cancer. METHOD: A retrospective population-based cohort study of all decedents in Western Australia who died January 2009 to December 2010 from a life-limiting condition considered amenable to palliative care. Hospital costs were assigned to each day of the last year of life for each decedent with a zero cost applied to days not in hospital. Day-specific hospital costs averaged over all decedents (cohort averaged) and decedents in hospital only (inpatient averaged) were estimated. Two-part models and generalised linear models were used. RESULTS: The cohort comprised 12,764 decedents who, combined, spent 451,236 (9.7%) days of the last year of life in hospital. Overall, periods of time receiving community-based specialist palliative care were associated with a 27% decrease from A$112 (A$110-A$114) per decedent per day to $A82 (A$78-A$85) per decedent per day of CA hospital costs. Community-based specialist palliative care was also associated a reduction of inpatient averaged hospital costs of 9% (7%-10%) to A$1030 per hospitalised decedent per day. Hospital cost reductions were observed for decedents with organ failures, chronic obstructive pulmonary disease, Alzheimer’s disease, Parkinson’s disease and cancer but not for motor neurone disease. Cost reductions associated with community-based specialist palliative care were evident 4 months before death for decedents with cancer and by one to 2 months before death for decedents dying from other conditions. CONCLUSION: Community-based specialist palliative care was associated with hospital cost reductions across multiple life-limiting conditions. BioMed Central 2017-12-08 /pmc/articles/PMC5721619/ /pubmed/29216873 http://dx.doi.org/10.1186/s12904-017-0256-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Spilsbury, Katrina
Rosenwax, Lorna
Community-based specialist palliative care is associated with reduced hospital costs for people with non-cancer conditions during the last year of life
title Community-based specialist palliative care is associated with reduced hospital costs for people with non-cancer conditions during the last year of life
title_full Community-based specialist palliative care is associated with reduced hospital costs for people with non-cancer conditions during the last year of life
title_fullStr Community-based specialist palliative care is associated with reduced hospital costs for people with non-cancer conditions during the last year of life
title_full_unstemmed Community-based specialist palliative care is associated with reduced hospital costs for people with non-cancer conditions during the last year of life
title_short Community-based specialist palliative care is associated with reduced hospital costs for people with non-cancer conditions during the last year of life
title_sort community-based specialist palliative care is associated with reduced hospital costs for people with non-cancer conditions during the last year of life
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721619/
https://www.ncbi.nlm.nih.gov/pubmed/29216873
http://dx.doi.org/10.1186/s12904-017-0256-2
work_keys_str_mv AT spilsburykatrina communitybasedspecialistpalliativecareisassociatedwithreducedhospitalcostsforpeoplewithnoncancerconditionsduringthelastyearoflife
AT rosenwaxlorna communitybasedspecialistpalliativecareisassociatedwithreducedhospitalcostsforpeoplewithnoncancerconditionsduringthelastyearoflife